Your browser doesn't support javascript.
loading
Progressive plasmacytoid variant bladder cancer with retroperitoneal dissemination: An autopsy case report.
Kohada, Yuki; Kaiho, Yasuhiro; Ito, Jun; Mikami, Jotaro; Anan, Go; Asano, Katsutoshi; Yaegashi, Toru; Murakami, Kazuhiro; Nakamura, Yasuhiro; Sato, Makoto.
Afiliação
  • Kohada Y; Division of Urology Faculty of Medicine Tohoku Medical and Pharmaceutical University Sendai Japan.
  • Kaiho Y; Division of Urology Faculty of Medicine Tohoku Medical and Pharmaceutical University Sendai Japan.
  • Ito J; Division of Urology Faculty of Medicine Tohoku Medical and Pharmaceutical University Sendai Japan.
  • Mikami J; Division of Urology Faculty of Medicine Tohoku Medical and Pharmaceutical University Sendai Japan.
  • Anan G; Division of Urology Faculty of Medicine Tohoku Medical and Pharmaceutical University Sendai Japan.
  • Asano K; Nihon Gene Research Laboratories Inc Sendai Japan.
  • Yaegashi T; Nihon Gene Research Laboratories Inc Sendai Japan.
  • Murakami K; Division of Pathology Faculty of Medicine Tohoku Medical and Pharmaceutical University Sendai Japan.
  • Nakamura Y; Division of Pathology Faculty of Medicine Tohoku Medical and Pharmaceutical University Sendai Japan.
  • Sato M; Division of Urology Faculty of Medicine Tohoku Medical and Pharmaceutical University Sendai Japan.
IJU Case Rep ; 3(5): 166-169, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32914061
ABSTRACT

INTRODUCTION:

Plasmacytoid urothelial carcinoma is a rare and aggressive variant of bladder cancer. CASE PRESENTATION A 75-year-old woman presented with plasmacytoid urothelial carcinoma with retroperitoneal dissemination was treated with chemotherapy. After an unsuccessful first-line chemotherapy with gemcitabine and cisplatin, we assessed circulating tumor cells; one such cell was found to be positive for programmed death-ligand 1. The patient received second-line chemotherapy with pembrolizumab. However, the tumor extended to the retroperitoneal organs, and the patient eventually died. Autopsy revealed a widespread diffuse scirrhous infiltration of the carcinoma into the retroperitoneum. However, distant metastasis was not observed.

CONCLUSION:

The evaluation of circulating tumor cells and autopsy revealed a disease state of progressive plasmacytoid urothelial carcinoma treated with pembrolizumab.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article